Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21039290 | 0.98 | PDK2 (0.32) | PDK2MEN1KMT2AKDM4ELMNA | |
| SCHEMBL21039284 | 0.95 | MEN1 (0.35) | PDK2MEN1KMT2AKDM4ELMNA | |
| SCHEMBL21039286 | 0.95 | MEN1 (0.35) | PDK2MEN1KMT2AKDM4ELMNA | |
| SCHEMBL22134217 | 0.94 | AHR (0.33) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22403659 | 0.94 | AHR (0.32) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22403541 | 0.94 | AHR (0.32) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22403479 | 0.94 | AHR (0.32) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22403540 | 0.92 | AHR (0.33) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL22036282 | 0.92 | AHR (0.33) | MEN1KMT2AKDM4ELMNAMAPT | |
| SCHEMBL17827459 | 0.92 | MMP12 (0.33) | PDK2MEN1KMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793068-B2 | Amine compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11793068-B2 | Amine compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-20210359230-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| US-11121329-B2 | Amine compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-09-14 | — | — | US | disclosed |
| US-20190165285-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359230-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | AOC2, H1-2, CHRM1 | PDK2 2276/4885MEN1 1998/4885KMT2A 329/4885 |
| US-11121329-B2 | Amine compound and organic electroluminescence device including the same | AOC2, H1-2, CHRM1 | PDK2 2276/4885MEN1 1998/4885KMT2A 329/4885 |
| US-20190165285-A1 | AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | ODC1, PNMT, SAT1 | PDK2 1854/4885MEN1 195/4885KMT2A 234/4885 |
| US-11793068-B2 | Amine compound and organic electroluminescence device including the same | AOC2, H1-2, CHRM1 | PDK2 2276/4885MEN1 1998/4885KMT2A 329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.